Vaccine Center
-
Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization
The U.S. Food and Drug Administration granted emergency use authorization Dec. 8 to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination that protects against COVID-19, discovered last year at Vanderbilt University Medical Center. Read MoreDec 10, 2021
-
Grant to Help Improve Flu Vaccines
Vanderbilt researchers have received a five-year, $9 million grant from the National Institutes of Health to design more effective flu vaccines and novel antibody therapies. Read MoreJul 31, 2015